Ferring signs global agreement to commercialise novel gene therapy for bladder cancer patients
rAd-IFN/Syn3, a novel gene therapy, is in Phase 3 development to treat high-grade non-muscle invasive bladder cancer patients, who…
-
-
Ferring acquires innovative biotechnology company and microbiome pioneer Rebiotix Inc.
• Rebiotix’s RBX2660 is a non-antibiotic treatment in Phase 3 development for the prevention of recurrent Clostridium difficile infection (CDI)…
-
Ferring’s CLENPIQ™ (sodium picosulfate, magnesium oxide, and anhydrous citric acid) Oral Solution for Colonoscopy Prep Now Available
First and only FDA-Approved, Ready-to-Drink Low-Volume Bowel Prep Parsippany, NJ – February 12, 2018 – Ferring Pharmaceuticals Inc. announced today…
-
Ferring’s ZOMACTON® (somatropin) for Injection Receives FDA Approval to Treat Growth Hormone Deficiency in Adults
Ferring Expands U.S. Endocrinology Portfolio PARSIPPANY, N.J., January 31, 2018 – Ferring Pharmaceuticals Inc. today announced that the U.S. Food…
-
FDA APPROVES FERRING’S CLENPIQ™ (sodium picosulfate, magnesium oxide, and anhydrous citric acid) ORAL SOLUTION FOR COLONOSCOPY PREP
New Ready-to-Drink Low-Volume Colonoscopy Prep in a Premixed Liquid Solution Parsippany, NJ – November 29, 2017 – The U.S. Food…
-
FERRING PHARMACEUTICALS PRESENTS NEW DATA COMPARING MENOPUR® (menotropins for injection) TO rFSH IN HIGH RESPONDER PATIENTS
PARSIPPANY, NJ (October 30, 2017) – Today Ferring Pharmaceuticals announced results from MEGASET HR, a 620 patient, prospective study comparing…
-
Ferring Pharmaceuticals to Donate $25,000 to Hurricane Harvey Relief
PARSIPPANY, N.J., August 29, 2017 – Ferring Pharmaceuticals announced today that it will donate $25,000 to help the people and…
-
Paul Navarre Joins Ferring Pharmaceuticals as Chief Executive Officer of Ferring Holding Inc.
PARSIPPANY, N.J., June 1, 2017 – Ferring Pharmaceuticals announced today that Paul Navarre has been appointed Chief Executive Officer of…
-
Ferring appoints Aaron Graff to Executive Board
Saint-Prex, Switzerland – 1 June 2017 – Ferring Pharmaceuticals announced today that Aaron Graff has been appointed Executive Vice President…
-
Ferring Pharmaceuticals Launches Two New Resources to Help Women Struggling with Infertility during National Infertility Awareness Week®
PARSIPPANY, NJ (April 24, 2017) – Infertility is no longer something that people feel they must discuss behind closed doors.…